SK Group, one of South Korea's massive, family-controlled businesses known as chaebol, is expected to list its vaccine making unit, SK Bioscience, on Thursday on the Korea Stock Exchange. SK ...

SK Group received a $2 billion boost from U.S. private equity giant KKR, which would help fuel the South Korean conglomerate’s plans to become a hydrogen powerhouse amid pressure to reduce ...